{"title":"[Luspatercept as first line in transfusion-dependant very low to intermediate risk myelodysplastic syndromes].","authors":"Urbain Tauveron-Jalenques, Gaspar Aspas Requena","doi":"10.1016/j.bulcan.2024.11.011","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":93917,"journal":{"name":"Bulletin du cancer","volume":" ","pages":"113-114"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin du cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.bulcan.2024.11.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}